Clinical Endocrinology

Next-generation sequencing for the genetic screening of phaeochromcytomas and paragangliomas: riding the new wave, but with caution

Authors

  • Rodrigo A. Toledo,

    1. Division of Hematology and Medical Oncology, Department of Medicine, Cancer Therapy and Research Center, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA
    Search for more papers by this author
  • Patricia L. M. Dahia

    Corresponding author
    1. Division of Hematology and Medical Oncology, Department of Medicine, Cancer Therapy and Research Center, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA
    2. Greehey Childhood Cancer Research Institute, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA
    • Correspondence: Patricia L. M. Dahia, Division of Hematology and Medical Oncology, Department Medicine, Cancer Therapy and Research Center, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA. Tel.: +1 210 567 4866; E-mail: dahia@uthscsa.edu

    Search for more papers by this author

  • Please see related paper on pages 25–33 of this issue.

No abstract is available for this article.

Ancillary